Susquehanna International Group’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-40,472
| Closed | -$2.75M | – | 11211 |
|
|
2019
Q3 | $2.75M | Sell |
40,472
-8,893
| -18% | -$611K | ﹤0.01% | 3639 |
|
|
2019
Q2 | $2.87M | Buy |
+49,365
| New | +$2.92M | ﹤0.01% | 3517 |
|
|
2019
Q1 | – | Sell |
-15,609
| Closed | -$1.16M | – | 10383 |
|
|
2018
Q4 | $1M | Buy |
15,609
+9,500
| +156% | +$666K | ﹤0.01% | 4651 |
|
|
2018
Q3 | $429K | Buy |
6,109
+730
| +14% | +$42.7K | ﹤0.01% | 6815 |
|
|
2018
Q2 | $271K | Sell |
5,379
-15,321
| -74% | -$608K | ﹤0.01% | 8047 |
|
|
2018
Q1 | $648K | Buy |
+20,700
| New | +$687K | ﹤0.01% | 6125 |
|
|
2017
Q1 | – | Sell |
-18,206
| Closed | -$539K | – | 10504 |
|
|
2016
Q4 | $535K | Buy |
+18,206
| New | +$555K | ﹤0.01% | 6835 |
|
|
2015
Q4 | – | Sell |
-28,582
| Closed | -$766K | – | 10260 |
|
|
2015
Q3 | $605K | Buy |
28,582
+17,698
| +163% | +$456K | ﹤0.01% | 6741 |
|
|
2015
Q2 | $302K | Sell |
10,884
-32,022
| -75% | -$903K | ﹤0.01% | 8521 |
|
|
2015
Q1 | $1.31M | Buy |
42,906
+33,478
| +355% | +$1.06M | ﹤0.01% | 5217 |
|
|
2014
Q4 | $301K | Sell |
9,428
-13,858
| -60% | -$451K | ﹤0.01% | 8133 |
|
|
2014
Q3 | $659K | Sell |
23,286
-14,910
| -39% | -$416K | ﹤0.01% | 6706 |
|
|
2014
Q2 | $1.05M | Sell |
38,196
-44,396
| -54% | -$1.18M | ﹤0.01% | 5967 |
|
|
2014
Q1 | $2.17M | Buy |
+82,592
| New | +$2.37M | ﹤0.01% | 4203 |
|
Susquehanna International Group's GHDX Position: Q4 2019 in Review
Susquehanna International Group sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 40,472 shares — an estimated $2.75M sold.
Susquehanna International Group first reported a position in GHDX in Q1 2014 and held it in 14 quarters. The position peaked at $2.87M in Q2 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Susquehanna International Group reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Susquehanna International Group sold 40,472 Genomic Health, Inc. shares in Q4 2019, an estimated $2.75M.
- Susquehanna International Group first reported a position in Genomic Health, Inc. in Q1 2014 and held it in 14 quarters.
- Susquehanna International Group's Genomic Health, Inc. position peaked at $2.87M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.